The View on GU | with Lalani and Wallis

De : Dr. Aly-Khan Lalani & Dr. Christopher Wallis
Écouter gratuitement

  • Résumé

  • There is currently a lack of organic multi-disciplinary discussion on what is truly impactful to the field of genitourinary (GU) cancers. The View on GU with Lalani and Wallis is a podcast that will integrate key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians. Importantly, Lalani and Wallis will also discuss the impact of governmental approvals and funding considerations on the GU oncology treatment landscape and provide practical considerations on the management of patients on new-to-market therapies.
    Dr. Aly-Khan Lalani & Dr. Christopher Wallis
    Afficher plus Afficher moins
Hygiène et vie saine Maladie et pathologies physiques
Afficher plus Afficher moins
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Episode 21: Prostate Cancer Imaging: When, Why and How? with Dr. Frédéric Pouliot

      Episode 21: Prostate Cancer Imaging: When, Why and How? with Dr. Frédéric Pouliot
      Apr 24 2025

      In this informative episode, Dr. Aly-Khan Lalani and Dr. Christopher Wallis are joined by Dr. Frédéric Pouilot, a urologist-oncologist and researcher in molecular imaging at the CHU de Québec-Université Laval Research Center. Together, they unpack the evolving role of PSMA PET in prostate cancer and how advanced imaging tools are reshaping treatment decisions. The conversation also looks ahead, to the future of dynamic imaging, and its potential to revolutionize personalized cancer care.


      The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca

      This podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, J&J, Merck, Pfizer, Eisai and AbbVie.
      Afficher plus Afficher moins
      31 min
    • Episode 20: Rolling Out Radioligand Therapy

      Episode 20: Rolling Out Radioligand Therapy
      Apr 11 2025

      In this must-listen episode, your hosts are joined by Dr. Zukotynski, a Professor of Medicine and Radiology at McMaster University and staff member at Hamilton Health Sciences. With her expertise in nuclear medicine and radiology, she delves into treatment logistics, the essential role of multidisciplinary coordination, and more.
      The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca

      This podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, J&J, Merck, Pfizer, Eisai and AbbVie.
      Afficher plus Afficher moins
      30 min
    • ASCO GU 2025 Commentary: Breaking down the latest in kidney cancer

      ASCO GU 2025 Commentary: Breaking down the latest in kidney cancer
      Feb 20 2025

      Episode 19 is the final part of a mini-series from the 2025 ASCO Genitourinary Cancers Symposium in San Francisco! After diving into prostate and bladder cancers in the first two episodes, Dr. Aly-Khan Lalani and Dr. Christopher Wallis are wrapping with an in-depth look at kidney cancer, diving into research, studies and developments shared at the symposium.


      The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take-home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca


      This podcast has been made possible through unrestricted financial support by Bayer, Astellas, J&J, Tolmar, Merck, and Pfizer.
      Afficher plus Afficher moins
      28 min

    Ce que les auditeurs disent de The View on GU | with Lalani and Wallis

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Commentaires Audible.fr

    Commentaires Amazon
    Il n'y a pas encore de critique disponible pour ce titre.